Dow Down 0.92% Nasdaq Down 0.83%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
6.34 Up 0.01(0.16%) Oct 22, 3:59PM EDT
Prev Close:6.33
Open:6.33
Bid:6.34 x 100
Ask:6.50 x 400
1y Target Est:10.25
Beta:0.5
Next Earnings Date:N/A
Day's Range:6.07 - 6.51
52wk Range:4.36 - 8.22
Volume:28,618
Avg Vol (3m):16,531
Market Cap:204.25M
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TTHI

Comparison

Symbol% ChgMkt Cap
TTHIUp 0.16%204.25M
GSKUp 1.79%106.67B
MRKUp 0.69%160.13B
PFEUp 0.07%179.45B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.97
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback